19-5914619-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_004058.5(CAPS):c.140G>A(p.Arg47Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,613,650 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_004058.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPS | NM_004058.5 | c.140G>A | p.Arg47Gln | missense_variant | 3/5 | ENST00000588776.8 | NP_004049.3 | |
CAPS | NM_080590.4 | c.140G>A | p.Arg47Gln | missense_variant | 3/5 | NP_542157.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPS | ENST00000588776.8 | c.140G>A | p.Arg47Gln | missense_variant | 3/5 | 1 | NM_004058.5 | ENSP00000465883.2 | ||
ENSG00000267314 | ENST00000588891.1 | n.*235G>A | non_coding_transcript_exon_variant | 4/4 | 4 | ENSP00000468419.1 | ||||
ENSG00000267314 | ENST00000588891.1 | n.*235G>A | 3_prime_UTR_variant | 4/4 | 4 | ENSP00000468419.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152240Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000638 AC: 16AN: 250624Hom.: 1 AF XY: 0.0000737 AC XY: 10AN XY: 135604
GnomAD4 exome AF: 0.0000287 AC: 42AN: 1461410Hom.: 1 Cov.: 33 AF XY: 0.0000385 AC XY: 28AN XY: 727004
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152240Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74372
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at